679 related articles for article (PubMed ID: 15947026)
21. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
22. Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile.
Kobayashi Y; Hirano S
Toxicol Appl Pharmacol; 2008 Oct; 232(1):33-40. PubMed ID: 18619986
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of arsenic in Drosophila melanogaster and the genotoxicity of dimethylarsinic acid in the Drosophila wing spot test.
Rizki M; Kossatz E; Velázquez A; Creus A; Farina M; Fortaner S; Sabbioni E; Marcos R
Environ Mol Mutagen; 2006 Apr; 47(3):162-8. PubMed ID: 16304668
[TBL] [Abstract][Full Text] [Related]
24. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats.
Krüger K; Straub H; Hirner AV; Hippler J; Binding N; Musshoff U
Toxicol Appl Pharmacol; 2009 Apr; 236(1):115-23. PubMed ID: 19371632
[TBL] [Abstract][Full Text] [Related]
25. Trivalent arsenicals are bound to proteins during reductive methylation.
Naranmandura H; Suzuki N; Suzuki KT
Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
[TBL] [Abstract][Full Text] [Related]
26. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells.
Naranmandura H; Ogra Y; Iwata K; Lee J; Suzuki KT; Weinfeld M; Le XC
Toxicol Appl Pharmacol; 2009 Jul; 238(2):133-40. PubMed ID: 19442679
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
Vega L; Styblo M; Patterson R; Cullen W; Wang C; Germolec D
Toxicol Appl Pharmacol; 2001 May; 172(3):225-32. PubMed ID: 11312651
[TBL] [Abstract][Full Text] [Related]
28. Differential toxicity and gene expression in Caco-2 cells exposed to arsenic species.
Calatayud M; Devesa V; Vélez D
Toxicol Lett; 2013 Mar; 218(1):70-80. PubMed ID: 23353816
[TBL] [Abstract][Full Text] [Related]
29. Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes.
Ferrario D; Croera C; Brustio R; Collotta A; Bowe G; Vahter M; Gribaldo L
Toxicology; 2008 Jul; 249(2-3):102-8. PubMed ID: 18524450
[TBL] [Abstract][Full Text] [Related]
30. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
Sakurai T; Kaise T; Matsubara C
Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
[TBL] [Abstract][Full Text] [Related]
31. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
32. The cyto- and genotoxicity of organotin compounds is dependent on the cellular uptake capability.
Dopp E; Hartmann LM; von Recklinghausen U; Florea AM; Rabieh S; Shokouhi B; Hirner AV; Obe G; Rettenmeier AW
Toxicology; 2007 Apr; 232(3):226-34. PubMed ID: 17316952
[TBL] [Abstract][Full Text] [Related]
33. Speciation of arsenic in biological samples.
Mandal BK; Ogra Y; Anzai K; Suzuki KT
Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.
Naranmandura H; Xu S; Sawata T; Hao WH; Liu H; Bu N; Ogra Y; Lou YJ; Suzuki N
Chem Res Toxicol; 2011 Jul; 24(7):1094-103. PubMed ID: 21648415
[TBL] [Abstract][Full Text] [Related]
35. Subcellular distribution of inorganic and methylated arsenic compounds in human urothelial cells and human hepatocytes.
Dopp E; von Recklinghausen U; Hartmann LM; Stueckradt I; Pollok I; Rabieh S; Hao L; Nussler A; Katier C; Hirner AV; Rettenmeier AW
Drug Metab Dispos; 2008 May; 36(5):971-9. PubMed ID: 18256204
[TBL] [Abstract][Full Text] [Related]
36. Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay.
Tsuchiya T; Tanaka-Kagawa T; Jinno H; Tokunaga H; Sakimoto K; Ando M; Umeda M
Toxicol Sci; 2005 Apr; 84(2):344-51. PubMed ID: 15647599
[TBL] [Abstract][Full Text] [Related]
37. Arsenic-induced bladder cancer in an animal model.
Cohen SM; Ohnishi T; Arnold LL; Le XC
Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
[TBL] [Abstract][Full Text] [Related]
38. Stability of arsenic species and insoluble arsenic in human urine.
Chen YC; Amarasiriwardena CJ; Hsueh YM; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1427-33. PubMed ID: 12433722
[TBL] [Abstract][Full Text] [Related]
39. Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay.
Colognato R; Coppedè F; Ponti J; Sabbioni E; Migliore L
Mutagenesis; 2007 Jul; 22(4):255-61. PubMed ID: 17369186
[TBL] [Abstract][Full Text] [Related]
40. Response of pepper plants (Capsicum annum L.) on soil amendment by inorganic and organic compounds of arsenic.
Száková J; Tlustos P; Goessler W; Pavlíková D; Schmeisser E
Arch Environ Contam Toxicol; 2007 Jan; 52(1):38-46. PubMed ID: 17031752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
